650.00
+10.00
(1.56%)
May 24 - Close
KOSDAQ
data delayed by 20 mins -
Disclaimer
Currency in KRW
| Range | 640.00 - 662.00 |
| 52 week | 600.00 - 990.00 |
| Open | 643.00 |
| Vol / Avg. | 555,161.00/496,959.00 |
| Mkt cap | 19.69B |
| P/E | - |
| Div/yield | - |
| EPS | -660.82 |
| Shares | 30.30M |
| Beta | - |
| Inst. own | - |
Key stats and ratios
| Q4 (Dec '06) | 2010 | |
| Net profit margin | -15.41% | -8.82% |
| Operating margin | -11.73% | 1.25% |
| EBITD margin | - | 3.26% |
| Return on average assets | -15.24% | -5.12% |
| Return on average equity | -70.11% | -20.61% |
| Employees | 274 | - |
| Carbon Disclosure Rating | - | - |
Address
1539-5, DongDong-Ri, Uiryeong-Eup
UIRYEONG, 636803
South Korea
+82-2-34905105 (Phone)
+82-2-34905129 (Fax)
UIRYEONG, 636803
South Korea
+82-2-34905105 (Phone)
+82-2-34905129 (Fax)
Website links
External links
Advertisement
Description
KYUNG NAM PHARM.CO., LTD. is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company�s products are grouped into four categories: vitamin products, placenta products, health food and general pharmaceuticals. The Company provides vitamin products under the brand name LEMONA. It supplies health food such as lactobacillus products through convenient stores and marts. The placenta products include human placenta related injections and drinks. The general pharmaceuticals include athletes foot therapeutic agents, inflammatory drugs, cold remedies, multi-nutrients and others. On October 18, 2011, the Company merged with HwaSung Bio Pharm Co., Ltd, which is engaged in the placenta materials business.
Officers and directors
| Chang Hwan Oh | Chief Executive Officer, Director | |
| Eun Huh | Head-Business, Managing Director | |
| Byeong Seop Hwang | Internal Auditor | |
| Chang Ju Lee | Director | |
| Cheol Min Kang | Director | |
| Cheol Choi | Non-Executive Independent Director |